BillionToOne (BLLN) Stock Price, Quote, News & History | Benzinga

SPY778.57+0.60%QQQ751.38+0.51%BTC/USD83,509.71+0.71%DIA516.21+0.89%GLD384.50+1.55%TLT77.97+0.12%

BillionToOne Inc (BLLN) Stock Price, Quote, News & History

BLLNNASDAQ

Trade with Public

Trade with Public

$98.09

2.682.81%

Last update: Oct 9, 4:00 PM

$96.00

0.590.62%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$94.46

Close

$98.09

Volume / Avg.

323.51K / 690.82K

Day Range

$98.09 - $98.09

52 Wk Range

61.96 - 150.44

Market Cap

$4.50B

P/E Ratio

133.44

Dividend Yield

-

Exchange

NASDAQ

RSI

42

Short Interest

10.78%

Days to Cover

3.88

Recent BillionToOne, Inc. News

Medicare Lab Fee Changes Impact BillionToOne, CareDx Differently

CMS aligns 2027 clinical lab fees with private payors to save $1 billion, yielding positive updates for CareDx and BillionToOne tests.

Vandana Singh

Jim Cramer: 'You Could Make Some Money With This 5.6% Yield'

Jim Cramer likes Babcock & Wilcox and Smithfield Foods. He also advises taking some profits on BillionToOne, and calls Eton Pharma a winner.

Avi Kapoor

BillionToOne Stock (BLLN) Falls After Hours: Here's What's Driving the Move

BillionToOne stock fell after hours after reporting second-quarter financial results.

Tanya Rawat

Jim Cramer: Design Therapeutics Is 'Pure Spec,' Buy This Health Care Stock

Cramer likes Silicon Motion, whose shares fell 2.2% to settle at $263.85 on Thursday. Wynn shares declined 0.8% to close at $95.43.

Avi Kapoor

Joby Aviation Is 'Too Risky,' But This Industrial Stock Is A 'Winner': Jim Cramer

Cramer shared his thoughts on various stocks, calling Joby Aviation too risky, BillionToOne a winner, Boston Scientific caught in competition, Rocket Lab a winner, and Pinnacle West Capital a good company. He also endorsed Intuitive Machines as a speculative stock.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

45.35M

Investing Cash Flow (TTM)

-12.22M

Financing Cash Flow (TTM)

326.54M

Free Cash Flow (TTM)

33.13M

Capital Expenditure (TTM)

-12.22M

Net Change in Cash (TTM)

359.67M

Analyst Trends and Forecast

3

May

1

Jun

2

Aug

1

Sep

1

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$4.23B

PE Ratio (TTM)

133.44

PE Ratio (FWD)

58.14

PEG Ratio (TTM)

-

PS Ratio (TTM)

11.24

PB Ratio (TTM)

8.38

Earnings Yield % (TTM)

0.75%

Earnings Yield % (FWD)

1.72%

EV / EBITDA (TTM)

81.51

Price / EBITDA (TTM)

88.88

Price / Free Cash Flow (TTM)

134.79

Book Value / Share

$11.38

Company Debt

Total Debt

$91.03M

LT Debt

$91.03M

LT Debt Issuance (TTM)

$30.05M

LT Debt Repayment (TTM)

-$1.07M

Total Cash

$548.63M

Debt to Equity

0.27

Issuance of Debt (TTM)

$28.98M

Repayment of Debt (TTM)

-$1.07M